Felix Dietlein

Felix Dietlein

UNVERIFIED PROFILE

Are you Felix Dietlein?   Register this Author

Register author
Felix Dietlein

Felix Dietlein

Publications by authors named "Felix Dietlein"

Are you Felix Dietlein?   Register this Author

18Publications

883Reads

10Profile Views

Propranolol und Morbus Parkinson.

Nuklearmedizin 2018 02 21;57(1):1-3. Epub 2018 Feb 21.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3413/Nukmed-0947-17-11DOI Listing
February 2018

The tumour suppressor CYLD regulates the p53 DNA damage response.

Nat Commun 2016 08 26;7:12508. Epub 2016 Aug 26.

Institute for Genetics, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD) and Centre for Molecular Medicine (CMMC), University of Cologne, Joseph-Stelzmann-Straβe 26, Cologne 50931, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ncomms12508DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5007442PMC
August 2016

Molecular pathways: exploiting tumor-specific molecular defects in DNA repair pathways for precision cancer therapy.

Clin Cancer Res 2014 Dec;20(23):5882-7

Department of Internal Medicine, University Hospital of Cologne, Cologne, Germany. Cologne Excellence Cluster on Cellular Stress Response in Aging-Associated Diseases, University of Cologne, Cologne, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-14-1165DOI Listing
December 2014

Cancer-specific defects in DNA repair pathways as targets for personalized therapeutic approaches.

Trends Genet 2014 Aug 10;30(8):326-39. Epub 2014 Jul 10.

Department of Internal Medicine, University Hospital of Cologne, 50931 Cologne, Germany; Cologne Excellence Cluster on Cellular Stress Response in Aging-Associated Diseases, University of Cologne, 50674 Cologne, Germany. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.tig.2014.06.003DOI Listing
August 2014

A functional cancer genomics screen identifies a druggable synthetic lethal interaction between MSH3 and PRKDC.

Cancer Discov 2014 May 20;4(5):592-605. Epub 2014 Feb 20.

1Department of Translational Genomics; 2Institute of Pathology; 3Cologne Excellence Cluster on Cellular Stress Response in Aging-Associated Diseases, University of Cologne; 4Department of Internal Medicine, University Hospital of Cologne, Cologne, Germany; and 5Michael F. Price Center, Albert Einstein College of Medicine, Bronx, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/2159-8290.CD-13-0907DOI Listing
May 2014

Inferring primary tumor sites from mutation spectra: a meta-analysis of histology-specific aberrations in cancer-derived cell lines.

Hum Mol Genet 2014 Mar 26;23(6):1527-37. Epub 2013 Oct 26.

Center for Integrated Oncology.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/hmg/ddt539DOI Listing
March 2014

Cell-autonomous and non-cell-autonomous mechanisms of transformation by amplified FGFR1 in lung cancer.

Cancer Discov 2014 Feb 3;4(2):246-57. Epub 2013 Dec 3.

1Department of Translational Genomics, University of Cologne; 2Max-Planck-Institute for Neurological Research; Institutes of 3Pathology and 4Virology, University of Cologne;5Department I of Internal Medicine and Center for Integrated Oncology, University Hospital of Cologne; 6Blackfield AG, Cologne; 7Technical University Dortmund, Dortmund, Germany; 8Medical Oncology and 9Institute of Pathology, Cantonal Hospital, Luzern; 10Novartis Pharma AG, Basel, Switzerland; and 11Division of Natural Products Chemistry, CSIR-Indian Institute of Chemical Technology, Tarnaka, Hyderabad, India.

View Article

Download full-text PDF

Source
http://cancerdiscovery.aacrjournals.org/cgi/doi/10.1158/2159
Publisher Site
http://dx.doi.org/10.1158/2159-8290.CD-13-0323DOI Listing
February 2014